CA
HCAT icon

Cliff Asness’s Health Catalyst HCAT Stock Holding History

Cliff Asness’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749K Sell
376,586
-166,658
-31% -$241K ﹤0.01% 3173
2026
Q1 		$690K Buy
543,244
+458,307
+540% +$862K ﹤0.01% 2968
2025
Q4 		$203K Sell
84,937
-14,821
-15% -$40.5K ﹤0.01% 3354
2025
Q3 		$284K Sell
99,758
-15,256
-13% -$52.2K ﹤0.01% 3109
2025
Q2 		$434K Sell
115,014
-53,330
-32% -$210K ﹤0.01% 2693
2025
Q1 		$763K Buy
168,344
+149,981
+817% +$794K ﹤0.01% 2187
2024
Q4 		$130K Sell
18,363
-11,813
-39% -$94.1K ﹤0.01% 2738
2024
Q3 		$246K Sell
30,176
-58,152
-66% -$420K ﹤0.01% 2488
2024
Q2 		$564K Buy
+88,328
New +$567K ﹤0.01% 2004
2023
Q2 		– Sell
-26,324
Closed -$307K – 2226
2023
Q1 		$307K Sell
26,324
-91,712
-78% -$1.17M ﹤0.01% 1941
2022
Q4 		$1.25M Buy
118,036
+42,652
+57% +$412K ﹤0.01% 1473
2022
Q3 		$731K Buy
75,384
+52,043
+223% +$689K ﹤0.01% 1639
2022
Q2 		$338K Buy
+23,341
New +$398K ﹤0.01% 1818

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cliff Asness's HCAT Position: Q2 2026 in Review

Cliff Asness reduced its Health Catalyst (HCAT) stake by 31% in Q2 2026, selling an estimated $241K and leaving 376,586 shares worth $749K. The position accounts for ﹤0.01% of the portfolio, ranked #3173.

Cliff Asness first reported a position in HCAT in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.25M in Q4 2022. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Cliff Asness held 376,586 shares of Health Catalyst worth $749K as of Q2 2026.
  • Cliff Asness sold 166,658 Health Catalyst shares in Q2 2026, an estimated $241K.
  • Health Catalyst made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3173 holding.
  • Cliff Asness first reported a position in Health Catalyst in Q2 2022 and has held it in 13 quarters since.
  • Cliff Asness's Health Catalyst position peaked at $1.25M in Q4 2022.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.